Searched for
JANSSEN PHARMACEUTICA
New Zealand likely to keep borders shut for most of 2021 over COVID-19, says PM ArdernNew Zealand closed its borders to foreigners and non-residents in the spring of 2020, when the global COVID-19 crisis kicked off.
EU commission urges member states to speed up vaccinationIn non-binding recommendations published Tuesday, the European Commission also called on the 27 EU member states to accelerate the rollout ...
EU doubles COVID-19 vaccines order with Pfizer-BioNTechThe EU commission later detailed in a statement that the Commission has offered to member states to purchase an additional 200 million dose...
Hyderabad set to emerge as global hub for Covid-19 vaccine in 2021The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's ...
BioNTech, Pfizer ask Europe to quickly approve virus vaccineThe German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional a...
BE ties up with Janssen Pharmaceutica NV for coronavirus vaccine production"We are very pleased indeed to collaborate with an organisation like Johnson & Johnson. Given the magnitude of COVID-19 pandemic, our abili...
Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...
Strides Shasun up over 3% on USFDA clearanceStrides Shasun is a vertically integrated global pharmaceutical company headquartered in Bengaluru.
Eighteen stocks in focus on Thursday, 13 October 2016The Indian market is expected to open flat. Here is a list of top eighteen stocks that are likely to be in focus today.
Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
Piramal to buy select injectable brands from Janssen for up to $175 millionPiramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.
Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
Dishman Pharma hits 52-week high as drug maker gets licence to manufacture TB medicineDishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.
Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- Jubilant soars on drug discovery pact with Belgian firm
Pharma firm Jubilant Life Sciences soared over 11% after its US-based arm inked drug discovery pact with Belgium-based Janssen Pharmaceutic...
- Global trademark activities grew 5.3% in 2008
Activities related to filing international trademarks have recorded a growth of 5.3% in 2008, with 42,075 applications filed during the yea...